COMPUTED DESCRIPTORS
| Molecular Weight | 2055.5 g/mol |
|---|---|
| XLogP3 | -9.7 |
| Hydrogen Bond Donor Count | 32 |
| Hydrogen Bond Acceptor Count | 31 |
| Rotatable Bond Count | 77 |
| Exact Mass | 2054.2034150 g/mol |
| Monoisotopic Mass | 2054.2034150 g/mol |
| Topological Polar Surface Area | 887 Ų |
| Heavy Atom Count | 143 |
| Formal Charge | 0 |
| Complexity | 4210 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 20 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
NX-1207 is an investigational new drug for BPH, whose chemical entity and mechanism of action remain undisclosed. Nymox Pharmaceutical Corporation recently completed studies of NX-1207 for treatment of benign prostatic hyperplasia (BPH).